佐々木康綱 (Yasutsuna Sasaki) - マイポータル

基本情報

Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin

Wataru Ichikawa, Akio Ooyama, Etsuko Toda, Yoshikazu Sugimoto, Toshinori Oka, Takehiro Takahashi, Michio Shimizu, Yasutsuna Sasaki, Renzo Hirayama

CANCER CHEMOTHERAPY AND PHARMACOLOGY 58(6) 794-801 2006年12月
Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients

H Minami, K Kawada, Y Sasaki, T Igarashi, T Saeki, M Tahara, K Itoh, H Fujii

CANCER SCIENCE 97(3) 235-241 2006年3月
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5’-deoxy-fluorouridine (5’-DFUR).

Hiromichi Ebi, Yasushi Shigeoka, Toshiaki Saeki, Kenji Kawada, Tadahiko Igarashi, Noriko Usubuchi, Ryuzo Ueda, Hironobu Minami

Cancer Chemother. Pharmacol. 56(2) 205-211 2005年8月
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Br. J. Cancer 2004; 91:1425-1250,

W Ichikawa, T Takahashi, K Suto, T Yamashita, Z Nihei, Y Shirota, M Shimizu, R Hirayama

Br. J. Cancer 91 1425-1250 2004年4月